ASYMMETRIC DOUPOLY COMPETITION WITH INNOVATION SPILLOVER AND INPUT CONSTRAINTS
نویسندگان
چکیده
منابع مشابه
Fault-Tolerant Control of a Nonlinear Process with Input Constraints
A Fault-Tolerant Control (FTC) methodology has been presented for nonlinear processes being imposed by control input constraints. The proposed methodology uses a combination of Feedback Linearization and Model Predictive Control (FLMPC) schemes. The resulting constraints in the transformed process will be dependent on the actual evolving states, making their incorporation in the de...
متن کاملKnowledge Spillover and Innovation in Technological Clusters
Knowledge spillovers have been used to explain the increased rate of innovation that is found in technological clusters. The last two decades have seen an increasing interest by researchers trying to capture and measure the effects of these spillovers. However, very little is known about the mechanisms of knowledge exchange that take place in clusters. In this paper we draw on the current body ...
متن کاملCompetition and Innovation
Which kind of intellectual property regime is more favorable to innovation: one that enforces patents or one that does not? Economic theory is unable to answer this question, as valid arguments can be made both for and against patents; hence we must turn to empirical evidence. In this paper, we review empirical evidence gathered by other researchers and add new evidence of our own. We conclude ...
متن کاملCompetition and Innovation
The Department of Justice and the Federal Trade Commission have frequently raised innovation concerns as reasons to challenge mergers. This chapter surveys the economic theories of innovation incentives and considers how the theory may inform antitrust analysis for merger investigations and other conduct that involve innovation. Competition can promote innovation by reducing the value of failin...
متن کاملCompetition and Innovation
As finding breakthrough small-molecule drugs becomes more difficult, drug companies are increasingly turning to "large molecule" biologics. Although biologics represent many of the most promising new therapies for previously intractable diseases, they are extremely expensive. Moreover, the pathway for generic-type competition set up by Congress in 20 1o is unlikely to yield significant cost sav...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Business Economics and Management
سال: 2015
ISSN: 1611-1699,2029-4433
DOI: 10.3846/16111699.2013.823104